Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
04. November 2024 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient...
Recombinant Proteins Market Size to Reach USD 5.0 Billion by 2032, at a CAGR of 7.6% - SNS Insider
25. September 2024 09:08 ET
|
SNS Insider pvt ltd
Pune, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Recombinant Proteins Market Size & Growth Analysis: According to SNS Insider, the Recombinant Proteins Market Size valued at USD 2.5 billion in...
Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference
23. September 2024 09:50 ET
|
Dyadic International, Inc.
JUPITER, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient,...
Biologics Market Size to Surge to USD 855.8 Billion by 2031 with a 6.9% CAGR, Fueled by Advanced Targeting of Biological Pathways – Report by Transparency Market Research, Inc.
27. August 2024 17:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research, Inc. , Aug. 27, 2024 (GLOBE NEWSWIRE) -- As per the report published by Transparency Market Research, the global biologics market...
Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress
13. August 2024 16:05 ET
|
Dyadic International, Inc.
Alternative Proteins Entered into a development and commercialization partnership for the sale of animal-free recombinant albumin products with Proliant Health and BiologicalsEntered into a joint...
Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
21. März 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Recombinant Proteins Market Predicted to Garner US$ 704.6 Bn By 2033, At CAGR 13.5% | Marketresearch.biz
20. Februar 2024 01:01 ET
|
MarketResearch.biz
New York, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The recombinant proteins market was valued at USD 205.0 billion in 2023 with significant growth and is projected to reach at USD 704.6 billion by 2033...
Microbial Fermentation Technology Market revenue to hit USD 63 Billion by 2036, says Research Nester
06. Dezember 2023 06:00 ET
|
Research Nester
New York , Dec. 06, 2023 (GLOBE NEWSWIRE) -- The global microbial fermentation technology market size is expected to expand at 6% CAGR from 2024 to 2036. The market is anticipated to garner a...
Cancer Biologics Market Set to Surpass USD 185.0 Bn by 2031 Driven by Increasing Cancer Prevalence and Biotechnology Innovations, Reveals TMR Study
13. Juni 2023 06:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, June 13, 2023 (GLOBE NEWSWIRE) -- The global cancer biologics market was valued at US$ 94.5 Bn in 2022. It is projected to expand at a CAGR of 7.7% from 2023 to...
Biopharmaceuticals Contract Manufacturing Market Research 2023-2030 'Reports Insights'
27. Februar 2023 07:00 ET
|
REPORTSINSIGHTS CONSULTING PVT LTD
New York, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The Biopharmaceuticals Contract Manufacturing Market is projected to grow at a CAGR of 5.6% from 2023 to 2030, reaching a value of USD 27.6 Billion by...